POSTERS ASCO 2024

Neoplasias hematológicas

Discrasia de células plasmáticas

Long-term follow-up of ARI0002h (cesnicabtagene autoleucel), an academic point-of-care B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell strategy: Activity and safety after fractionated initial therapy and booster dose in 60 patients with relapsed/refractory multiple myeloma (RRMM).

Long-term follow-up of ARI0002h (cesnicabtagene autoleucel), an academic point-of-care B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell strategy: Activity and safety after fractionated initial therapy and booster dose in 60 patients with relapsed/refractory multiple myeloma (RRMM).

Abstract: 7544 Poster Bd #: 181

Poster

Descargar

Autor
Carlos Fernandez de Larrea, PhD

Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON